Baidu
map

JAMA Dermatol:遗传性大疱性表皮松解症流行病学研究

2016-08-16 Seven L 译 MedSci原创

目的:确定不同压型的遗传性大疱性表皮松解症(EB)在美国16年间的患病率和发病率。方法:前瞻性横截面和纵向研究。数据来自3271例EB患者,收集相关临床和实验室资料,以及其他相关相关信息,在两个时间框架内评估EB的发病率和患病率。结果:在注册资金的第一个5年,每100万个活产婴儿遗传性EB的总体发病率和患病率分别为19.60和8.22。当重新评估16年的研究,患病率上升到11.07,而总体发病率保

背景:大疱性表皮松解症(epidermolysis bullosa,EB)分为遗传性和获得性两种。遗传性EB至少包括23种不同类型,依据发病部位不同可分为三类:单纯型大疱性表皮松解症(simplexEB,EBS),水疱在表皮内;交界型大疱性表皮松解症(junctionalEB,JEB),水疱发生于透明层;营养不良型大疱性表皮松解症(dystrophic EB,DEB),水疱发生在致密下层。

目的:
研究者进行了一项研究,探究不同亚型遗传性大疱性表皮松解症(EB)在美国16年间的患病率和发病率。

方法:前瞻性横截面和纵向研究。数据来自3271例EB患者,收集相关临床和实验室资料,以及其他相关信息,在两个时间框架内评估EB的发病率和患病率。

结果:在注册资金的第一个5年,每100万个活产婴儿遗传性EB的总体发病率和患病率分别为19.60%和8.22%。当重新评估16年的研究,患病率上升到11.07%,而总体发病率保持不变,仍为19.57%。一些疾病亚群患者数量的增加。例如,在2002,EBS整体和局部EBS分别大大增加了30.4%和25.5%,广义中间EBS的患病率下降了76.7%。JEB或广义重症JEB的患病率没有显着的变化,虽然广义中间JEB患病率下降73%。

结论:在美国遗传性EB各亚型发病率精确估计现在是可利用的,有助于以后进行大规模的临床试验。

原始出处:

Jo-David Fine,et al. Epidemiology of Inherited Epidermolysis Bullosa Based on Incidence and Prevalence Estimates From the National Epidermolysis Bullosa Registry. JAMA Dermatol. Published online July 27, 2016.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1859972, encodeId=c11418599e2ae, content=<a href='/topic/show?id=cc73951054b' target=_blank style='color:#2F92EE;'>#遗传性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95105, encryptionId=cc73951054b, topicName=遗传性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Mon Aug 29 17:03:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140032, encodeId=e177140032d3, content=在美国遗传性EB各亚型发病率精确估计现在是可利用的,有助于以后进行大规模的临床试验..., beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 16:27:10 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140031, encodeId=3ac5140031d1, content=在美国遗传性EB各亚型发病率精确估计现在是可利用的。有助于以后进行大规模的临床试验~值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 16:26:44 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=103761, encodeId=0ffb103e61b9, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Thu Aug 25 18:41:00 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411246, encodeId=87da1411246e5, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Aug 18 01:03:00 CST 2016, time=2016-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412730, encodeId=ad091412e3049, content=<a href='/topic/show?id=12d343e9340' target=_blank style='color:#2F92EE;'>#大疱性表皮松解症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43793, encryptionId=12d343e9340, topicName=大疱性表皮松解症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee352889971, createdName=nian.wang1983, createdTime=Thu Aug 18 01:03:00 CST 2016, time=2016-08-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1859972, encodeId=c11418599e2ae, content=<a href='/topic/show?id=cc73951054b' target=_blank style='color:#2F92EE;'>#遗传性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95105, encryptionId=cc73951054b, topicName=遗传性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Mon Aug 29 17:03:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140032, encodeId=e177140032d3, content=在美国遗传性EB各亚型发病率精确估计现在是可利用的,有助于以后进行大规模的临床试验..., beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 16:27:10 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140031, encodeId=3ac5140031d1, content=在美国遗传性EB各亚型发病率精确估计现在是可利用的。有助于以后进行大规模的临床试验~值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 16:26:44 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=103761, encodeId=0ffb103e61b9, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Thu Aug 25 18:41:00 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411246, encodeId=87da1411246e5, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Aug 18 01:03:00 CST 2016, time=2016-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412730, encodeId=ad091412e3049, content=<a href='/topic/show?id=12d343e9340' target=_blank style='color:#2F92EE;'>#大疱性表皮松解症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43793, encryptionId=12d343e9340, topicName=大疱性表皮松解症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee352889971, createdName=nian.wang1983, createdTime=Thu Aug 18 01:03:00 CST 2016, time=2016-08-18, status=1, ipAttribution=)]
    2016-10-04 Carlos007

    在美国遗传性EB各亚型发病率精确估计现在是可利用的,有助于以后进行大规模的临床试验...

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1859972, encodeId=c11418599e2ae, content=<a href='/topic/show?id=cc73951054b' target=_blank style='color:#2F92EE;'>#遗传性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95105, encryptionId=cc73951054b, topicName=遗传性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Mon Aug 29 17:03:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140032, encodeId=e177140032d3, content=在美国遗传性EB各亚型发病率精确估计现在是可利用的,有助于以后进行大规模的临床试验..., beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 16:27:10 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140031, encodeId=3ac5140031d1, content=在美国遗传性EB各亚型发病率精确估计现在是可利用的。有助于以后进行大规模的临床试验~值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 16:26:44 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=103761, encodeId=0ffb103e61b9, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Thu Aug 25 18:41:00 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411246, encodeId=87da1411246e5, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Aug 18 01:03:00 CST 2016, time=2016-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412730, encodeId=ad091412e3049, content=<a href='/topic/show?id=12d343e9340' target=_blank style='color:#2F92EE;'>#大疱性表皮松解症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43793, encryptionId=12d343e9340, topicName=大疱性表皮松解症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee352889971, createdName=nian.wang1983, createdTime=Thu Aug 18 01:03:00 CST 2016, time=2016-08-18, status=1, ipAttribution=)]
    2016-10-04 Carlos007

    在美国遗传性EB各亚型发病率精确估计现在是可利用的。有助于以后进行大规模的临床试验~值得学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1859972, encodeId=c11418599e2ae, content=<a href='/topic/show?id=cc73951054b' target=_blank style='color:#2F92EE;'>#遗传性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95105, encryptionId=cc73951054b, topicName=遗传性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Mon Aug 29 17:03:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140032, encodeId=e177140032d3, content=在美国遗传性EB各亚型发病率精确估计现在是可利用的,有助于以后进行大规模的临床试验..., beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 16:27:10 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140031, encodeId=3ac5140031d1, content=在美国遗传性EB各亚型发病率精确估计现在是可利用的。有助于以后进行大规模的临床试验~值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 16:26:44 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=103761, encodeId=0ffb103e61b9, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Thu Aug 25 18:41:00 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411246, encodeId=87da1411246e5, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Aug 18 01:03:00 CST 2016, time=2016-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412730, encodeId=ad091412e3049, content=<a href='/topic/show?id=12d343e9340' target=_blank style='color:#2F92EE;'>#大疱性表皮松解症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43793, encryptionId=12d343e9340, topicName=大疱性表皮松解症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee352889971, createdName=nian.wang1983, createdTime=Thu Aug 18 01:03:00 CST 2016, time=2016-08-18, status=1, ipAttribution=)]
    2016-08-25 忠诚向上

    好好学习一下

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1859972, encodeId=c11418599e2ae, content=<a href='/topic/show?id=cc73951054b' target=_blank style='color:#2F92EE;'>#遗传性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95105, encryptionId=cc73951054b, topicName=遗传性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Mon Aug 29 17:03:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140032, encodeId=e177140032d3, content=在美国遗传性EB各亚型发病率精确估计现在是可利用的,有助于以后进行大规模的临床试验..., beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 16:27:10 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140031, encodeId=3ac5140031d1, content=在美国遗传性EB各亚型发病率精确估计现在是可利用的。有助于以后进行大规模的临床试验~值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 16:26:44 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=103761, encodeId=0ffb103e61b9, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Thu Aug 25 18:41:00 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411246, encodeId=87da1411246e5, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Aug 18 01:03:00 CST 2016, time=2016-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412730, encodeId=ad091412e3049, content=<a href='/topic/show?id=12d343e9340' target=_blank style='color:#2F92EE;'>#大疱性表皮松解症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43793, encryptionId=12d343e9340, topicName=大疱性表皮松解症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee352889971, createdName=nian.wang1983, createdTime=Thu Aug 18 01:03:00 CST 2016, time=2016-08-18, status=1, ipAttribution=)]
    2016-08-18 xugumin
  6. [GetPortalCommentsPageByObjectIdResponse(id=1859972, encodeId=c11418599e2ae, content=<a href='/topic/show?id=cc73951054b' target=_blank style='color:#2F92EE;'>#遗传性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95105, encryptionId=cc73951054b, topicName=遗传性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Mon Aug 29 17:03:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140032, encodeId=e177140032d3, content=在美国遗传性EB各亚型发病率精确估计现在是可利用的,有助于以后进行大规模的临床试验..., beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 16:27:10 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=140031, encodeId=3ac5140031d1, content=在美国遗传性EB各亚型发病率精确估计现在是可利用的。有助于以后进行大规模的临床试验~值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 16:26:44 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=103761, encodeId=0ffb103e61b9, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Thu Aug 25 18:41:00 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411246, encodeId=87da1411246e5, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Aug 18 01:03:00 CST 2016, time=2016-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412730, encodeId=ad091412e3049, content=<a href='/topic/show?id=12d343e9340' target=_blank style='color:#2F92EE;'>#大疱性表皮松解症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43793, encryptionId=12d343e9340, topicName=大疱性表皮松解症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee352889971, createdName=nian.wang1983, createdTime=Thu Aug 18 01:03:00 CST 2016, time=2016-08-18, status=1, ipAttribution=)]
Baidu
map
Baidu
map
Baidu
map